Share on StockTwits
 

HeartWare International (NASDAQ:HTWR) Insider Jeffrey Larose sold 15,342 shares of the stock on the open market in a transaction that occurred on Tuesday, January 7th. The stock was sold at an average price of $100.00, for a total value of $1,534,200.00. Following the completion of the sale, the insider now directly owns 4,925 shares in the company, valued at approximately $492,500. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Several analysts have recently commented on the stock. Analysts at JPMorgan Chase & Co. raised their price target on shares of HeartWare International from $125.00 to $131.00 in a research note to investors on Monday, December 16th. Separately, analysts at Canaccord Genuity raised their price target on shares of HeartWare International from $110.00 to $115.00 in a research note to investors on Tuesday, December 3rd. Finally, analysts at CRT Capital initiated coverage on shares of HeartWare International in a research note to investors on Tuesday, November 26th. They set a “buy” rating and a $109.00 price target on the stock. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $98.58.

HeartWare International (NASDAQ:HTWR) traded up 1.19% on Tuesday, hitting $100.22. 248,834 shares of the company’s stock traded hands. HeartWare International has a 1-year low of $69.31 and a 1-year high of $99.68. The stock’s 50-day moving average is $93.37 and its 200-day moving average is $85.5. The company’s market cap is $1.650 billion.

HeartWare International (NASDAQ:HTWR) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.69) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.83) by $0.14. The company had revenue of $54.80 million for the quarter, compared to the consensus estimate of $49.40 million. On average, analysts predict that HeartWare International will post $-3.11 earnings per share for the current fiscal year.

Heartware International, Inc (NASDAQ:HTWR) develops and manufactures small implantable heart pumps, or ventricular assist devices, for the treatment of advanced heart failure.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.